Vanguard Group Inc Bio Rad Laboratories, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,919,808 shares of BIO stock, worth $628 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,919,808
Previous 1,907,640
0.64%
Holding current value
$628 Million
Previous $638 Million
1.19%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding BIO
# of Institutions
466Shares Held
18.7MCall Options Held
19.5KPut Options Held
13.9K-
Black Rock Inc. New York, NY1.55MShares$507 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$341 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$319 Million3.36% of portfolio
-
Van Eck Associates Corp723KShares$237 Million0.3% of portfolio
-
First Eagle Investment Management, LLC714KShares$233 Million0.53% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.06B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...